Clinical Trial Update: Nesiritide and Vo2 Max in Heart Failure Patients [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating nesiritide and VO2 max in heart failure patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: University of Rochester | Conditions: Heart Failure | Phase 2 | Status: COMPLETED